Organizations Filed Purposes:
THE MUCOLIPIDOSIS TYPE IV FOUNDATION OPERATES SOLELY TO RAISE CONTRIBUTIONS FROM INDIVIDUALS AND COMPANIES IN ORDER TO FUND MEDICAL RESEARCH GRANTS. ALL MEDICAL RESEARCH GRANTS ARE PROVIDED TO RESEARCHERS STUDYING THE CAUSE AND SYMPTOMS OF MUCOLIPIDOSIS TYPE IV WITH THE HOPE OF FINDING A CURE FOR THIS DISEASE. ALL FUNDRAISING AND FUND DISTRIBUTION ACTIVITIES ARE CONDUCTED BY VOLUNTEERS THROUGHOUT THE YEAR. BOARD MEMBERS AND VOLUNTEERS LIVE THROUGHOUT THE US AND PROVIDE VARIOUS AMOUNTS OF TIME TO THE FOUNDATION.
RESEARCH TO CURE MUCOLIPIDOSIS TYPE IV EINSTEIN HOSPITAL
Executives Listed on Filing
Total Salary includes financial earnings, benefits, and all related organization earnings listed on tax filing
| Name | Title | Hours Per Week | Total Salary |
|---|
| Rebecca Oberman | EXECUTIVE DIRECTOR | 40 | $100,167 |
| Michael Friedman | BOARD MEMBER | 2 | $0 |
| Janet Price | BOARD MEMBER | 2 | $0 |
| David Reich | BOARD MEMBER | 2 | $0 |
| Paula Kutner | BOARD MEMBER | 2 | $0 |
| Caroline Gold | SECRETARY | 2 | $0 |
| Josh Gordon | TREASURER | 2 | $0 |
| Randy Gold | PRESIDENT | 2 | $0 |
Data for this page was sourced from XML published by IRS (
public 990 form dataset) from:
https://s3.amazonaws.com/irs-form-990/201623159349303267_public.xml